These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11464322)

  • 1. Is glutathione-S-transferase-pi expression a reliable predictor of chemoradiation response in cancer of the head and neck?
    Vural E; Alexiou M; Hunt J; Korourian S; Hanna E
    Am J Otolaryngol; 2001; 22(4):257-60. PubMed ID: 11464322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
    Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ
    Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
    Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
    Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
    Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T
    Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
    Bai F; Nakanishi Y; Kawasaki M; Takayama K; Yatsunami J; Pei XH; Tsuruta N; Wakamatsu K; Hara N
    Cancer; 1996 Aug; 78(3):416-21. PubMed ID: 8697385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase pi in squamous cell carcinoma of the head and neck.
    Bentz BG; Haines GK; Radosevich JA
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1642-7. PubMed ID: 11037818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J; Tan PH; Thiyagarajan J; Bay BH
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of multidrug resistance 1 and glutathione-S-transferase-Pi protein in nasopharyngeal carcinoma.
    Chen CL; Sheen TS; Lou IU; Huang AC
    Hum Pathol; 2001 Nov; 32(11):1240-4. PubMed ID: 11727264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression and amplification of glutathione S-transferase pi gene in head and neck squamous cell carcinomas.
    Wang X; Pavelic ZP; Li Y; Gleich L; Gartside PS; Pavelic L; Gluckman JL; Stambrook PJ
    Clin Cancer Res; 1997 Jan; 3(1):111-4. PubMed ID: 9815545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
    Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N
    Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
    Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
    Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer.
    Nishimura T; Newkirk K; Sessions RB; Andrews PA; Trock BJ; Rasmussen AA; Montgomery EA; Bischoff EK; Cullen KJ
    Clin Cancer Res; 1996 Nov; 2(11):1859-65. PubMed ID: 9816141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.
    Harpole DH; Moore MB; Herndon JE; Aloia T; D'Amico TA; Sporn T; Parr A; Linoila I; Allegra C
    Clin Cancer Res; 2001 Mar; 7(3):562-9. PubMed ID: 11297249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
    J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.